CE vs EOLS
Celanese Corporation (CE) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
CE currently screens at market cap $5.92B. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the CE and EOLS stock pages for the full models.
Not investment advice.